|
|
| Phases of Development | Preclinical | Phase I | Phase II | Phase III | Registration | Marketed |
|---|
| Autoimmune | 0 | 1 | 0 | 0 | 1 | 0 | | Dermatology | 0 | 1 | 0 | 0 | 0 | 0 | | Genitourinary | 0 | 1 | 1 | 0 | 0 | 0 | | Inflammation | 0 | 0 | 1 | 0 | 0 | 0 | | Neurology | 1 | 1 | 1 | 1 | 0 | 1 | | Ophthalmic | 0 | 0 | 1 | 0 | 0 | 0 |
|
|
Products Targeting Transient receptor potential vanilloid 1 (TRPV1) (VR1)